The Judith Jane Mason & Harold Stannet Williams Memorial Foundation (‘the Mason Foundation’) is a charitable trust that supports medical and scientific research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Alzheimer’s disease.
The Mason Foundation was established as a result of a generous donation in 2003 from Judith Jane Mason (nee Williams). She also made a number of top-up contributions during her lifetime. The Foundation is named in honour of the benefactor and her father, Harold Stannett Williams, who Ms Mason described as
“a most intelligent, wonderful and charitable man”.
Goal of the Mason Foundation
The goal of The Mason Foundation is to achieve enduring, positive impact in the areas of ME/CFS and Alzheimer’s disease through funding medical research principally into the causes, prevention and/or management of these diseases.
The Mason Foundation - Alzheimer’s research grants
Equity Trustees and the National Foundation for Medical Research and Innovation (NFMRI) announced a new partnership in 2018 to advance research focused on Alzheimer’s disease.
Together, we will be seeking expressions of interests for projects investigating potential treatments and/or cure for Alzheimer’s Disease that align with NFMRI’s strategy and mission. Further information is provided on NFMRI's website.
2018 applications are now closed
The Mason Foundation – ME/CFS research grants
The Mason Foundation ME/CFS research grants are overseen by a National Medical Advisory Panel.
To deliver on its goal into the future, the Mason Foundation has identified the need to enhance its current grants program. For more information download the guidelines
Applications are now closed
In addition to the 2018 ME/CFS call for research grant applications, it is also the intention of The Mason Foundation to issue an Expression of Interest (EOI) for the establishment and operation of a patient registry/database for ME/CFS research and a limited scale biobank. Research grant applications leveraging these resources in future will be a priority. It is anticipated that EOIs will be sought towards the beginning of 2019.